As the U.S. considers how to help the globe get vaccinated, corporate shareholders got traction in recent demands that COVID-19 vaccine makers Pfizer and J&J report on how they're considering access and pricing in the pandemic. CQ Roll Call's Laura Weiss reports on what's next for vaccine makers.